Literature DB >> 17177646

Saliva and serum lithium monitoring in hospitalized patients and possibility to replace serum to saliva.

Nafija Serdarević1, Franc Kozjek, Ivan Malesic.   

Abstract

The lithium ions concentration in human serum and saliva was determined using dry-slide technology Vitros 250 Analyser (Ortho Clinical Diagnostic) and atomic absorption spectrometry Perkin Elmer 403 (AAS). We analyzed lithium ions in 100 serum and saliva specimens of patients after oral administration of lithium carbonate (3 x 300 mg) Jadran, Galen Laboratory Rijeka. Saliva and blood were taken 2 and 12 hours after the last dose. At the same time lithium ions at samples of blood and saliva were determined with both methods which showed high level of correlation. The mean difference of lithium ions between saliva and serum was statistically significant for p<0.05 using t student test. At saliva we got constant of elimination Kel = 0.02(-1)h and elimination half life (t(1/2)) was t(1/2)=34.6 h. For serum was t(1/2)= 24 h what means that lithium ions elimination is slower from saliva then from serum. That is the reason why probably concentration at saliva is higher then at serum. Lithium elimination is two compartment pharmacokinetic model where important part of compartment are saliva and salivary glands. At a certain point in medical treatment it could be expected to use controlled determination of lithium ions in saliva with serum as control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177646     DOI: 10.17305/bjbms.2006.3116

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  4 in total

1.  Saliva testing as a means to monitor therapeutic lithium levels in patients with psychiatric disorders: Identification of clinical and environmental covariates, and their incorporation into a prediction model.

Authors:  Georgia M Parkin; Michael J McCarthy; Soe H Thein; Hillary L Piccerillo; Nisha Warikoo; Douglas A Granger; Elizabeth A Thomas
Journal:  Bipolar Disord       Date:  2021-09-24       Impact factor: 5.345

2.  Lithium chloride could aggravate brain injury caused by 3-nitropropionic acid.

Authors:  Aleksandra Milutinović
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

Review 3.  Advances in Therapeutic Monitoring of Lithium in the Management of Bipolar Disorder.

Authors:  Mahsa Sheikh; Meha Qassem; Iasonas F Triantis; Panicos A Kyriacou
Journal:  Sensors (Basel)       Date:  2022-01-19       Impact factor: 3.576

4.  Provider Perspectives on the Current Use of Lithium Medications and Lithium Monitoring Practices for Psychiatric Conditions.

Authors:  Georgia M Parkin; Elizabeth A Thomas
Journal:  Neuropsychiatr Dis Treat       Date:  2022-09-15       Impact factor: 2.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.